| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/28/2006 | WO2006138507A1 Use of sanglifehrin in hcv |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137790A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137509A1 Cyclic amine derivative containing ppar regulator |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 12/28/2006 | WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 12/28/2006 | WO2006106358A3 Use of nk-3 receptor antagonists for the treatment of nausea and vomiting |
| 12/28/2006 | WO2006102112A3 Prokineticin 1 receptor |
| 12/28/2006 | WO2006101521A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006099314A8 Use of methylnaltrexone and related compounds to treat constipation in terminally ill patients |
| 12/28/2006 | WO2006042733A3 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 12/28/2006 | WO2006018698A3 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 12/28/2006 | WO2005122678A3 A pharmaceutical composition having prokinetic effect and comprising o-(3-piperidino-2-hydroxypropyl) nicotinic amidoxime |
| 12/28/2006 | US20060293543 Isolation of lutein from alfalfa |
| 12/28/2006 | US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 12/28/2006 | US20060293371 Prodrug and process for producing the same |
| 12/28/2006 | US20060293363 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293335 Riboflavin derivative and its manufacture and uses |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3 |
| 12/28/2006 | US20060293275 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/28/2006 | US20060293221 Mucosal repair by TFF2 peptides |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292184 Bioadhesive liquid composition which is substantially free of water |
| 12/28/2006 | US20060292171 Moderating the effect of endotoxins |
| 12/28/2006 | US20060292148 Antihuman TNF-alpha antibody activity lowering inhibitor |
| 12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 12/28/2006 | US20060292133 Use of lactobacillus salivarius |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/28/2006 | CA2613253A1 Combination comprising amino alcohol derivatives as immunosuppressants |
| 12/28/2006 | CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof |
| 12/28/2006 | CA2612922A1 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 12/28/2006 | CA2612133A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | CA2612112A1 Process for the production of intermediates for the preparation of tricyclic benzimidazoles |
| 12/28/2006 | CA2611151A1 Use of sanglifehrin in hcv |
| 12/28/2006 | CA2583345A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736469A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-Fluorophenyl)ethyl]-4-piperidinemethanol |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1736173A1 Damaged tissue therapeutic agent and therapeutic method |
| 12/27/2006 | EP1736165A1 Antidiarrheal agent for livestock and poultry |
| 12/27/2006 | EP1736164A1 Agent for preventing or suppressing hepatopathy and functional food for preventing or suppressing hepatopathy |
| 12/27/2006 | EP1736158A2 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 12/27/2006 | EP1736156A1 STABILIZED 4-AMINO-5-CHLORO-N-¬(1R,3r,5S)-8-METHYL-8- AZABICYCLO¬3.2.1|OCT-3-YL|-2-¬1-METHYLBUT-2-YNYLOXY|-BENZAMIDE CONTAINING COMPOSITION |
| 12/27/2006 | EP1736152A2 Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds |
| 12/27/2006 | EP1736144A2 Orally disintegrable tablets |
| 12/27/2006 | EP1736143A1 Process for producing medicine |
| 12/27/2006 | EP1735304A1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists |
| 12/27/2006 | EP1734990A1 Use of corticotroph-derived glycoprotein hormone to treat liver steatosis |
| 12/27/2006 | EP1734946A2 Method of using punicic acid to enhance immune response and prevent metabolic disorders |
| 12/27/2006 | EP1734943A1 Use of capsaicin and capsaicinoids for diagnosing chemical hypersensibility |
| 12/27/2006 | EP1585748B1 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1379515B1 Lipid lowering biphenylcarboxamides |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1345895B1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1280912B1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP1185618B1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 12/27/2006 | EP0980246B1 Therapy for constipation |
| 12/27/2006 | EP0844875B1 Use of basic l-carnitine and acyl derivatives for lowering ceramide levels |
| 12/27/2006 | CN1886506A Protein expressed in nk cell |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886385A Crystals of phenylalanine derivatives and production methods thereof |
| 12/27/2006 | CN1886375A Piperidine compound and method for producing same |
| 12/27/2006 | CN1886147A Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 12/27/2006 | CN1886144A Moderating the effect of endotoxins |
| 12/27/2006 | CN1884295A Oxygen deficient induction factor1 antisense oligonucleotide and its uses |
| 12/27/2006 | CN1883704A Hepatitis A-hepatitis E combined vaccine and preparation method thereof |
| 12/27/2006 | CN1883703A Serine protease inhibitor of Rana grahami, its gene and application |
| 12/27/2006 | CN1883692A Calculi dissolving dan with climbing fern, chickens gizzard-membrane and curcuma root |
| 12/27/2006 | CN1883690A Medicine for treating hepatic fibrosis and preparation method thereof |
| 12/27/2006 | CN1883687A Liver-benefiting health food made from pure Chinese medicine |
| 12/27/2006 | CN1883684A Medicinal capsule for treating gastrointestinal disease and preparation method thereof |
| 12/27/2006 | CN1883681A Method for preparing deer embryo-contained tonifying soft capsule |
| 12/27/2006 | CN1883675A Chinese medicinal oral liquid for treating appendicitis and enteritis |